We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
RSA Insurance Group PLC
RSA:LSE
518.50
GBX
+80.70
+18.43%
Hikma Pharmaceuticals PLC
HIK:LSE
2,321
GBX
+241.00
+11.59%
Virgin Money Holdings (UK) PLC
VM.:LSE
415.00
GBX
+40.60
+10.84%
Domino's Pizza Group PLC
DOM:LSE
887.50
GBX
+84.00
+10.45%
Drax Group PLC
DRX:LSE
277.40
GBX
+24.90
+9.86%
Melrose Industries PLC
MRO:LSE
278.90
GBX
+24.50
+9.63%
Lonmin PLC
LMI:LSE
59.10
GBX
+4.30
+7.85%
GKN PLC
GKN:LSE
316.60
GBX
+21.60
+7.32%
Informa PLC
INF:LSE
576.50
GBX
+34.00
+6.27%
Kaz Minerals PLC
KAZ:LSE
168.00
GBX
+9.80
+6.19%
As of Jul 28 2015 16:36 BST.

Companies news

Who bought who
Deal status
Deal value
Date
St. Jude Medical IncacquiredThoratec CorpAnnounced3.52bn22 Jul 2015
Westinghouse Air Brake Technologies CorpacquiredFaiveley Transport SAAnnounced809.98m27 Jul 2015
First Majestic Silver CorpacquiredSilverCrest Mines IncAnnounced117.98m27 Jul 2015
Batero Gold CorpacquiredCB Gold IncAnnounced6.48m24 Jul 2015
1-4 of 4 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Royal Mail faces fine for raising barriers
RBS to reduce Citizens stake below 25%
Pfizer chief has ‘courage’ to pursue deals
Low oil price and rising dollar hit Pemex
HeidelbergCement takes over Italcementi

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply